Smadar Levin-Zaidman

Weizmann Institute of Science

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Weizmann Institute of Science

Research Subjects

Research Interests

Smadar Levin-Zaidman has a total of 121 co-authors. Here are the top co-authors by number of shared publications:

Ayelet Erez
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel
21 shared publications
Efrat Ben-Zeev
The Whol Drug Discovery institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine Weizmann Institute of Science 7610001 Rehovot Israel
21 shared publications
Lital N. Adler
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
21 shared publications
Maxim Itkin
Weizmann Institute of Science
21 shared publications
Sergey Malitsky
Weizmann Institute of Science
21 shared publications
Alexander Brandis
Weizmann Institute of Science 5 Department of Life Sciences Core Facilities Rehovot, Israel
20 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Features of chosen cell lines for DepMap analysis
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 2 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Features of chosen cell lines for DepMap analysis
Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 10 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Characteristics of patients’ dispensing history of papaverin and statins up to 6 months prior to cancer diagnosis
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 10 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Characteristics of patients’ dispensing history of papaverin and statins up to 6 months prior to cancer diagnosis
Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 11 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
HR status of cancer patients used in papaverine cohort
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 11 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
HR status of cancer patients used in papaverine cohort
Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 3 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Hazard ratio (HR) status of cancer patients used in the cohort
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 5 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Hazard ratio (HR) status of cancer patients used in the cohort
Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Characteristics of patients’ dispensing history of sildenafil and statins up to 6 months prior to cancer diagnosis
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 4 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Characteristics of patients’ dispensing history of sildenafil and statins up to 6 months prior to cancer diagnosis
Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Characteristics of male patients’ dispensing history of sildenafil and statins up to 6 months prior to cancer diagnosis
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 6 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Characteristics of male patients’ dispensing history of sildenafil and statins up to 6 months prior to cancer diagnosis
Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 8 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Characteristics of diabetic patients’ dispensing history of sildenafil and statins up to 6 months prior to cancer diagnosis
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 8 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
Characteristics of diabetic patients’ dispensing history of sildenafil and statins up to 6 months prior to cancer diagnosis
Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
HR status of male cancer patients used in the cohort
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 7 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
HR status of male cancer patients used in the cohort
Open Access
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 9 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
HR status of diabetic cancer patients used in the cohort
Website
Google Scholar
- 2 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 9 from PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway
by Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, et al.
HR status of diabetic cancer patients used in the cohort

Show all